Jimenez Freddy A.
SEC insider (Form 3/4/5 filer). CIK 0001838114. SVP & GENERAL COUNSEL at Celldex Therapeutics, Inc. (CLDX). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in HAMPTON, NJ.
Companies Jimenez Freddy A. has filed insider reports for
- Celldex Therapeutics, Inc. (CLDX): Officer, SVP & GENERAL COUNSEL
Jimenez Freddy A.
CIK: 0001838114
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Celldex Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 25, 2026CLDX
Celldex Therapeutics, Inc.
AwardDirectIncentive Stock Option (right to buy)
93K shares- - Dec 4, 2025CLDX
Celldex Therapeutics, Inc.
SaleDirect4.2K shares at avg. $29.09$121K - Aug 13, 2025CLDX
Celldex Therapeutics, Inc.
SaleDirect341 shares at avg. $23.95$8K - Aug 13, 2025CLDX
Celldex Therapeutics, Inc.
SaleDirect430 shares at avg. $25.41$11K - Jun 5, 2025CLDX
Celldex Therapeutics, Inc.
AwardDirectIncentive Stock Option (right to buy)
75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 | CLDX Celldex Therapeutics, Inc. | Award Incentive Stock Option (right to buy) | 93,000 | - | - | Direct |
| Dec 4, 2025 | CLDX Celldex Therapeutics, Inc. | Sale | 4,166 | $29.09 | $121,210 | Direct |
| Aug 13, 2025 | CLDX Celldex Therapeutics, Inc. | Sale | 341 | $23.95 | $8,167 | Direct |
| Aug 13, 2025 | CLDX Celldex Therapeutics, Inc. | Sale | 430 | $25.41 | $10,928 | Direct |
| Jun 5, 2025 | CLDX Celldex Therapeutics, Inc. | Award Incentive Stock Option (right to buy) | 75,000 | - | - | Direct |
1-5 of 5 transactions